跳至主要内容
临床试验/NCT03289403
NCT03289403已完成2 期

The Role of Immunomodulatory Treatment in Success of ICSI in Patients Who Have Infertility With Autoimmune Thyroiditis

Aljazeera Hospital1 个研究点 分布在 1 个国家目标入组 194 人开始时间: 2018年3月7日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
194
试验地点
1
主要终点
The Number of Participants Who Achieved clinical Pregnancy

研究概览

简要总结

The aim of the work is to determine whether the use of immunomodulatory drugs could improve the reproductive of outcome of infertile patients who have autoimmune thyroiditis with positive autoimmune antibodies undergoing IVF-ET.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Infertility patients who have autoimmune thyroiditis With positive autoimmune thyroiditis and TSH level above 2 IU.

排除标准

  • All patients who have other autoimmune diseases especially antiphospholipid syndrome, hepatitis c viral disease.
  • Patients who have any medical disorders ( eg. D.M. HTN .Epilepsy ....)

研究组 & 干预措施

Study group

Experimental

Patients will receive thyroxine , low dose aspirin , low dose selenium, Calcium and vitamin D and immunomodulatory drugs(prednisolone, hydroxychloroquine, azathioprin, IV immunoglobulins)

干预措施: Immunomodulatory (Drug)

Control group

Active Comparator

Patients will receive thyroxine , low dose aspirin , low dose selenium, Calcium and vitamin D.

干预措施: Thyroxine (Drug)

结局指标

主要结局

The Number of Participants Who Achieved clinical Pregnancy

时间窗: 6 weeks after embryo transfer

次要结局

  • The Number of Participants Who Achieved Ongoing Pregnancy(18 weeks after embryo transfer)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验